Catherine Delva

582 total citations
21 papers, 412 citations indexed

About

Catherine Delva is a scholar working on Dermatology, Surgery and Nephrology. According to data from OpenAlex, Catherine Delva has authored 21 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 4 papers in Surgery and 4 papers in Nephrology. Recurrent topics in Catherine Delva's work include Skin Protection and Aging (5 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Dermatologic Treatments and Research (3 papers). Catherine Delva is often cited by papers focused on Skin Protection and Aging (5 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Dermatologic Treatments and Research (3 papers). Catherine Delva collaborates with scholars based in France, Germany and Russia. Catherine Delva's co-authors include Sylvie Lancrenon, B. Cutuli, Youlia Kirova, B. De Lafontan, C. Lemanski, C. Tunon de Lara, Frédéric Lioté, Alain Saraux, Hang‐Korng Ea and Pascal Guggenbuhl and has published in prestigious journals such as PLoS ONE, Molecules and Journal of the American Academy of Dermatology.

In The Last Decade

Catherine Delva

20 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Delva France 11 126 114 114 73 68 21 412
Zaven H. Chakmakjian United States 11 78 0.6× 94 0.8× 77 0.7× 22 0.3× 21 0.3× 20 589
Nicté Figueroa‐Vega Mexico 13 39 0.3× 11 0.1× 125 1.1× 13 0.2× 28 0.4× 26 758
Fotios Koskeridis Greece 9 26 0.2× 26 0.2× 137 1.2× 7 0.1× 47 0.7× 13 348
Wendy J. Brickman United States 15 120 1.0× 70 0.6× 141 1.2× 3 0.0× 51 0.8× 35 562
Ursula Perks United Kingdom 7 55 0.4× 44 0.4× 61 0.5× 7 0.1× 22 0.3× 8 473
Tadayuki Ayabe Japan 10 60 0.5× 12 0.1× 130 1.1× 14 0.2× 75 1.1× 24 384
Paulina Ratajczak United States 11 20 0.2× 22 0.2× 228 2.0× 271 3.7× 39 0.6× 17 772
Tang Jiang China 11 15 0.1× 12 0.1× 42 0.4× 27 0.4× 23 0.3× 21 415
Soumia Brakta United States 8 613 4.9× 11 0.1× 48 0.4× 7 0.1× 73 1.1× 16 1.2k

Countries citing papers authored by Catherine Delva

Since Specialization
Citations

This map shows the geographic impact of Catherine Delva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Delva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Delva more than expected).

Fields of papers citing papers by Catherine Delva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Delva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Delva. The network helps show where Catherine Delva may publish in the future.

Co-authorship network of co-authors of Catherine Delva

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Delva. A scholar is included among the top collaborators of Catherine Delva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Delva. Catherine Delva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Draelos, Zoé Kececioglu, Wei Liu, Mukta Sachdev, et al.. (2023). International Consensus on Anti-Aging Dermocosmetics and Skin Care for Clinical Practice Using the RAND/UCLA Appropriateness Method. Journal of Drugs in Dermatology. 23(1). 1337–1343.
3.
Stefanaki, Irene, et al.. (2022). Topical formulation containing peptides and vitamin C in ampoules improves skin aging signs: Results of a large, international, observational study. Journal of Cosmetic Dermatology. 21(9). 3910–3916. 6 indexed citations
4.
Reygagne, Pascal, Victor Desmond Mandel, Catherine Delva, et al.. (2021). An anti‐hair loss treatment in the management of mild androgenetic alopecia: Results from a large, international observational study. Dermatologic Therapy. 34(6). e15134–e15134. 6 indexed citations
6.
Kérob, Delphine, et al.. (2020). <p>A Corrective Cosmetic Improves the Quality of Life and Skin Quality of Subjects with Facial Blemishes Caused by Skin Disorders</p>. Clinical Cosmetic and Investigational Dermatology. Volume 13. 253–257. 5 indexed citations
8.
Tan, Jerry, Martina Kerscher, Catherine Delva, et al.. (2019). Vichy mineralizing water with hyaluronic acid is effective and well tolerated as an adjunct to the management of various dermatoses and after esthetic procedures. Journal of Cosmetic Dermatology. 19(3). 682–688. 10 indexed citations
9.
Nguyen‐Thanh, Viêt, Romain Guignard, Sylvie Lancrenon, et al.. (2018). Effectiveness of a Fully Automated Internet-Based Smoking Cessation Program: A Randomized Controlled Trial (STAMP). Nicotine & Tobacco Research. 21(2). 163–172. 14 indexed citations
10.
Lancrenon, Sylvie, Hang‐Korng Ea, Charles Lambert, et al.. (2017). GOSPEL 3: Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century – comparison with 2006 EULAR Recommendations. Joint Bone Spine. 84(4). 447–453. 17 indexed citations
11.
Tessier, Christian, Kim Sweers, Ariel Frajerman, et al.. (2016). Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations. Translational Psychiatry. 6(10). e906–e906. 67 indexed citations
12.
Pascart, Tristan, Sylvie Lancrenon, Catherine Delva, et al.. (2016). GOSPEL 2 – Colchicine for the treatment of gout flares in France – a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age. Joint Bone Spine. 83(6). 687–693. 25 indexed citations
13.
Cutuli, B., Isabella Palumbo, P. Barbieri, et al.. (2016). Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences. Cancer/Radiothérapie. 20(4). 292–298. 10 indexed citations
14.
Cutuli, B., B. De Lafontan, Youlia Kirova, et al.. (2015). Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiation Oncology. 10(1). 110–110. 21 indexed citations
15.
Lancrenon, Sylvie, et al.. (2014). Gait Velocity Is an Indicator of Cognitive Performance in Healthy Middle-Aged Adults. PLoS ONE. 9(8). e103211–e103211. 11 indexed citations
16.
Lioté, Frédéric, Sylvie Lancrenon, Pascal Guggenbuhl, et al.. (2012). GOSPEL: Prospective survey of gout in France. Part I: Design and patient characteristics (n=1003). Joint Bone Spine. 79(5). 464–470. 35 indexed citations
19.
Cutuli, B., C. Tunon de Lara, Lorenzo Livi, et al.. (2011). Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases. Critical Reviews in Oncology/Hematology. 81(1). 29–37. 27 indexed citations
20.
Cutuli, B., D. Serin, Youlia Kirova, et al.. (2009). Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Critical Reviews in Oncology/Hematology. 73(3). 246–254. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026